InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Reine Allan, 首席财务官. Officer active across 2 companies, notably Foghorn Therapeutics Inc.. Cumulatively, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €130k. Activity tracked since 9 August 2021. The latest transaction was disclosed on 21 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Allan Reine is the Chief Financial Officer at Foghorn Therapeutics Inc. He is responsible for financial management and strategic planning. Allan plays a vital role in optimizing financial resources and achieving the company's objectives.